Seeking Alpha

Five major drug companies are still in the hunt to acquire Amylin (AMLN) as the auction enters...

Five major drug companies are still in the hunt to acquire Amylin (AMLN) as the auction enters its final stage, Reuters reports, with final bids expected to start coming in at the end of the week. The runners and riders are Novartis (NVS), Sanofi (SNY), Bristol Myers (BMY), AstraZenica (AZN) and Merck (MRK). (See also)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|